| # | Drug | Count |
|---|---|---|
| 0 | AMBRISENTAN | 564 |
| 1 | TREPROSTINIL | 452 |
| 2 | TADALAFIL | 358 |
| 3 | SILDENAFIL CITRATE | 341 |
| 4 | PREDNISONE | 314 |
| 5 | MACITENTAN | 308 |
| 6 | MYCOPHENOLATE MOFETIL | 255 |
| 7 | BOSENTAN | 252 |
| 8 | METHOTREXATE SODIUM | 239 |
| 9 | FUROSEMIDE | 221 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALLOGENIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDC | 1 | 0.0345 |
| 1 | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | 2 | 0.0161 |
| 2 | DEMECLOCYCLINE | 2 | 0.0088 |
| 3 | PALIFERMIN | 3 | 0.0077 |
| 4 | SODIUM HYPOCHLORITE | 2 | 0.0077 |
| 5 | GADODIAMIDE | 25 | 0.0074 |
| 6 | AVOBENZONE, HOMOSALATE, OCTISALAT, OCTOCRYLENE | 1 | 0.0071 |
| 7 | AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE | 1 | 0.0067 |
| 8 | SELEXIPAG | 159 | 0.0061 |
| 9 | CHROMIC CHLORIDE | 5 | 0.0058 |
| # | Drug class | Count |
|---|---|---|
| 0 | Endothelin Receptor Antagonist [EPC] | 864 |
| 1 | Corticosteroid [EPC] | 521 |
| 2 | Prostacycline Vasodilator [EPC] | 515 |
| 3 | Phosphodiesterase 5 Inhibitor [EPC] | 464 |
| 4 | Loop Diuretic [EPC] | 269 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 239 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 239 |
| 7 | Proton Pump Inhibitor [EPC] | 225 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 197 |
| 9 | Kinase Inhibitor [EPC] | 163 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 3 | 0.0077 |
| 1 | Prostacyclin Receptor Agonist [EPC] | 159 | 0.0061 |
| 2 | Paramagnetic Contrast Agent [EPC] | 26 | 0.0057 |
| 3 | Serotonin-4 Receptor Agonist [EPC] | 3 | 0.0046 |
| 4 | Endothelin Receptor Antagonist [EPC] | 864 | 0.0043 |
| 5 | Lymphocyte Growth Factor [EPC] | 5 | 0.0040 |
| 6 | Prostacycline Vasodilator [EPC] | 515 | 0.0037 |
| 7 | Blood Viscosity Reducer [EPC] | 15 | 0.0035 |
| 8 | Phosphodiesterase 5 Inhibitor [EPC] | 464 | 0.0034 |
| 9 | Prostacycline [EPC] | 3 | 0.0032 |